Rinvecalinase Alfa

N/A

Report date: 2026/04/29 20:02:18

Base Information

Drug NameRinvecalinase Alfa
Drug Alias NamerhKLK-1-DiaMedicaDM-99DM-199
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant hormone
Mechanisms of ActionProstaglandin agonistsT lymphocytes modulatorsKininogens stimulants
TargetsKininogens
Therapy Area/IndicationsIschemic StrokeDiabetes Mellitus, Type 2Diabetes Mellitus +[7
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumCanadaUnited States +[12
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesDiamedica
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsIschemic StrokePre-EclampsiaKidney Diseases +[4
Inactive IndicationsDiabetes Mellitus, Type 2Diabetes MellitusRenal Insufficiency, Chronic

Other Information

ATC CodeN/A
Related LinksN/A